Diagnostic and therapeutic implements based on advanced Biotechnology should be available in low-income countries

Diagnostic and therapeutic implements based on advanced Biotechnology should be available in low-income countries

Authors

  • Matteo Bertelli EBTNA-LAB, Rovereto (TN), Italy; MAGI EUREGIO, Bolzano, Italy; Alliance for Health Promotion - in Official Relations with the World Health Organization (WHO), Geneva, Switzerland
  • Stefano Paolacci MAGI'S LAB
  • Tommaso Beccari European Biotechnology Thematic Network Association, Perugia, Italy; Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy
  • Munis Dundar European Biotechnology Thematic Network Association, Perugia, Italy; Department of Medical Genetics, Erciyes University, Kayseri, Turkey
  • Gabriella Sozanski Alliance for Health Promotion - in Official Relations with the World Health Organization (WHO), Geneva, Switzerland
  • Stanislav Miertus International Centre for Applied Research and Sustainable Technology (ICARST), Bratislava, Slovakia
  • Jan Miertus Genius n.o., Trnava, Slovakia
  • Lucio Luzzatto Muhimbili University of Health and Allied Sciences, Dar-es-Salaam, Tanzania

Keywords:

biotechnology, developing countries, sustainable development goals, World Health Organization

Abstract

N.A.

Downloads

Published

30-09-2019

How to Cite

1.
Diagnostic and therapeutic implements based on advanced Biotechnology should be available in low-income countries. Acta Biomed [Internet]. 2019 Sep. 30 [cited 2024 Mar. 29];90(10-S):5-6. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/8771